---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-085772"
form_type: "8-K"
ticker: null
cik: "0001661460"
company_name: "Poseida Therapeutics, Inc."
filed_at: "2023-03-30T23:59:59+00:00"
generated_at: "2026-06-17T09:17:27.108752+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Poseida Therapeutics dismisses PwC, appoints EY as independent auditor for FY2023

## Summary
- Audit Committee dismissed PwC on March 27, 2023; PwC's 2022 report included an emphasis-of-matter paragraph on additional financing needs.
- No disagreements or reportable events between Poseida and PwC during fiscal years 2022, 2021, and subsequent interim period.
- Ernst & Young LLP appointed as new independent registered public accounting firm for fiscal year ending December 31, 2023.
- Company had not consulted EY on accounting principles or audit opinions prior to engagement.

## SEC filing metadata
- accession: 0001193125-23-085772
- form_type: 8-K
- cik: 0001661460
- company_name: Poseida Therapeutics, Inc.
- filed_at: 2023-03-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 4.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1661460/000119312523085772/0001193125-23-085772-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1661460/000119312523085772/d471529d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-085772
- JSON: https://secwatch.observer/filing/0001193125-23-085772.json
- Plain text: https://secwatch.observer/filing/0001193125-23-085772.txt

## Key facts
- Auditor Changes
  Poseida Therapeutics, Inc. dismissed PricewaterhouseCoopers LLP as its auditor.
  - Action: dismissal
  - Auditor: PricewaterhouseCoopers LLP
  - Successor: Ernst & Young LLP
  source text: On March 27, 2023, the Audit Committee dismissed PricewaterhouseCoopers LLP (“PwC”) as the Company’s independent registered public accounting firm.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1661460/000119312523085772/0001193125-23-085772-index.htm
- Auditor Changes
  Poseida Therapeutics, Inc. engaged Ernst & Young LLP as its auditor.
  - Action: engagement
  - Auditor: Ernst & Young LLP
  source text: On March 27, 2023, after conducting an auditor evaluation and selection process, the Audit Committee approved the appointment of Ernst & Young LLP (“EY”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1661460/000119312523085772/0001193125-23-085772-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.